|
You are here: Home: BCU 3|2004: Faculty Disclosures
FACULTY DISCLOSURES
As a provider accredited by the ACCME, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:
|
| John F R Robertson, MD, FRCS |
Grants/Research Support and Honorarium: AstraZeneca Pharmaceuticals LP |
| Gary H Lyman, MD, MPH, FRCP |
Grants/Research Support: Amgen Inc, GlaxoSmithKline Consultant: Amgen Inc, Ortho Biotech Products LP |
| Daniel R Budman, MD, FACP |
Grants/Research Support: Aventis Pharmaceuticals Inc, Eisai Inc, Eli Lilly and Company, GlaxoSmithKline, Novartis Pharmaceuticals, Roche Laboratories Inc Consultant: Eisai Inc Honorarium: Amgen Inc, Aventis Pharmaceuticals Inc, GlaxoSmithKline, Roche Laboratories Inc |
| Francesco Boccardo, MD |
Grants/Research Support: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company Honorarium: AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Eli Lilly and Company, Novartis Pharmaceuticals |
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.
|
|
|
|
